We have probed the mTORC1-dependent mechanism of SESN2 that suppresses endometrial cancer cells, although further experimental studies would be required to explore the role of SESN2-mediated autophagy in inhibiting endometrial cancer growth and progression. This evidence concerns the gene SESN2 and endometrial cancer.